109 related articles for article (PubMed ID: 9498929)
1. Congenital myasthenic syndromes: clinical and genetic analysis of 18 patients.
Abicht A; Müller-Felber W; Fischer P; Jakob I; Kürz L; Rudel R; Mortier W; Pongratz D; Lochmüller H
Eur J Med Res; 1997 Dec; 2(12):515-22. PubMed ID: 9498929
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
[TBL] [Abstract][Full Text] [Related]
3. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.
Harper CM; Engel AG
Ann Neurol; 1998 Apr; 43(4):480-4. PubMed ID: 9546329
[TBL] [Abstract][Full Text] [Related]
4. A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome.
Gomez CM; Maselli R; Gammack J; Lasalde J; Tamamizu S; Cornblath DR; Lehar M; McNamee M; Kuncl RW
Ann Neurol; 1996 Jun; 39(6):712-23. PubMed ID: 8651643
[TBL] [Abstract][Full Text] [Related]
5. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor.
Ohno K; Anlar B; Ozdirim E; Brengman JM; DeBleecker JL; Engel AG
Ann Neurol; 1998 Aug; 44(2):234-41. PubMed ID: 9708546
[TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenic syndromes: experiments of nature.
Engel AG; Ohno K; Sine SM
J Physiol Paris; 1998 Apr; 92(2):113-7. PubMed ID: 9782453
[TBL] [Abstract][Full Text] [Related]
7. Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome.
Croxen R; Newland C; Beeson D; Oosterhuis H; Chauplannaz G; Vincent A; Newsom-Davis J
Hum Mol Genet; 1997 May; 6(5):767-74. PubMed ID: 9158151
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.
Nichols P; Croxen R; Vincent A; Rutter R; Hutchinson M; Newsom-Davis J; Beeson D
Ann Neurol; 1999 Apr; 45(4):439-43. PubMed ID: 10211467
[TBL] [Abstract][Full Text] [Related]
9. [Congenital myasthenic syndrome].
Araga S
Nihon Rinsho; 2008 Jun; 66(6):1177-80. PubMed ID: 18540366
[TBL] [Abstract][Full Text] [Related]
10. A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome.
Müller JS; Abicht A; Christen HJ; Stucka R; Schara U; Mortier W; Huebner A; Lochmüller H
Neuromuscul Disord; 2004 Nov; 14(11):744-9. PubMed ID: 15482960
[TBL] [Abstract][Full Text] [Related]
11. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
[TBL] [Abstract][Full Text] [Related]
12. [Congenital diseases of neuromuscular transmission: congenital myasthenia syndromes].
Sieb JP
Nervenarzt; 1995 Feb; 66(2):105-10. PubMed ID: 7715748
[TBL] [Abstract][Full Text] [Related]
13. Genes at the junction--candidates for congenital myasthenic syndromes.
Vincent A; Newland C; Croxen R; Beeson D
Trends Neurosci; 1997 Jan; 20(1):15-22. PubMed ID: 9004414
[TBL] [Abstract][Full Text] [Related]
14. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita.
Brownlow S; Webster R; Croxen R; Brydson M; Neville B; Lin JP; Vincent A; Newsom-Davis J; Beeson D
J Clin Invest; 2001 Jul; 108(1):125-30. PubMed ID: 11435464
[TBL] [Abstract][Full Text] [Related]
16. Congenital myasthenic syndromes: progress over the past decade.
Engel AG; Ohno K; Sine SM
Muscle Nerve; 2003 Jan; 27(1):4-25. PubMed ID: 12508290
[TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenic syndrome (CMS) in three European kinships due to a novel splice mutation (IVS7 - 2 A/G) in the epsilon acetylcholine receptor (AChR) subunit gene.
Barisic N; Schmidt C; Sidorova OP; Herczegfalvi A; Gekht BM; Song IH; Stucka R; Karcagi V; Abicht A; Lochmüller H
Neuropediatrics; 2002 Oct; 33(5):249-54. PubMed ID: 12536367
[TBL] [Abstract][Full Text] [Related]
18. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa.
Richard P; Gaudon K; Haddad H; Ammar AB; Genin E; Bauché S; Paturneau-Jouas M; Müller JS; Lochmüller H; Grid D; Hamri A; Nouioua S; Tazir M; Mayer M; Desnuelle C; Barois A; Chabrol B; Pouget J; Koenig J; Gouider-Khouja N; Hentati F; Eymard B; Hantaï D
Neurology; 2008 Dec; 71(24):1967-72. PubMed ID: 19064877
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches.
Schara U; Della Marina A; Abicht A
Neuropediatrics; 2012 Aug; 43(4):184-93. PubMed ID: 22911480
[TBL] [Abstract][Full Text] [Related]
20. Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.
Croxen R; Hatton C; Shelley C; Brydson M; Chauplannaz G; Oosterhuis H; Vincent A; Newsom-Davis J; Colquhoun D; Beeson D
Neurology; 2002 Jul; 59(2):162-8. PubMed ID: 12141316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
